Evidence map›Paper›PMID 41970929›Full record

ArticleACS omega2026

Stimuli-Responsive MOF Nanocarriers for Precision Pulmonary Delivery of Aloperine in Acute Lung Injury.

Jing Yu, Madappa C Maridevaru, Jun Gao, Sibtain Muhammad, Jieyan Li, Yinghe Zhang, Jing Zhao, Kun Tang, Shaohua Wang, Bing Guo and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jing YuSecond Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Madappa C MaridevaruSchool of Science, Harbin Institute of Technology, Shenzhen 518055, China.
Jun GaoSecond Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Sibtain MuhammadSchool of Science, Harbin Institute of Technology, Shenzhen 518055, China.
Jieyan LiSchool of Science, Harbin Institute of Technology, Shenzhen 518055, China.
Yinghe ZhangShenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application, Harbin Institute of Technology, Shenzhen 518055, China.
Jing ZhaoSecond Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Kun TangSecond Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Shaohua WangLaboratory Diagnosis Center for Infectious Disease, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Bing GuoSchool of Science, Harbin Institute of Technology, Shenzhen 518055, China.ORCID https://orcid.org/0000-0001-7981-0644
Wensen PanSecond Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute lung injury (ALI), known as a severe respiratory disease, often leads to increased inflammation, harm to the alveolar-capillary barrier, and decreased oxygenation, with high morbidity and mortality rates. Herein, we study aloperine (ALO), a hydrophobic anti-inflammatory alkaloid with traditional Chinese medicine origins for ALI treatment. Importantly, effective ALO encapsulation is made possible over a zirconium-based UiO-66-NH

Identifiers

PMID41970929
PMCPMC13063073

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.